Alzheimer's Disease, Dementia, and CBD

Alzheimer's Disease (AD), according to the Journal of American Medical Association (JAMA), is the most common form of dementia. Dementia is defined as the "loss of intellectual ability" according to the JAMA. Symptoms of Alzheimer's Disease include: confusion, the lack of ability to remember things, the loss of knowledge regarding the ability to perform everyday skills or tasks, the inability to consistently recognize family or friends, the loss of problem solving skills, and a tendency to display agitated behavior. Alzheimer's disease, throughout the years, has become a major and growing threat to the public health. According to the American Medical Association, Alzheimer's disease was the sixth leading cause of all deaths in the United States in 2007. Many of the medicines used currently have many unsafe side effects and, at this point, there has not been a medication identified that would potentially stop the disease or reverse its progression. Possibly until now, the recent research taking place in the cannabis industry has identified that cannabinoids (CBD) may be part of the solution.

Research has discovered that CBD, a derivative of the cannabis plant without THC (the psychoactive ingredient known to get you "high") present, has many benefits related to reducing or even inhibiting the cognitive impairment associated with Alzheimer's disease. People who are suffering from the effects of Alzheimer's disease either lose nerve cells or experience mutation of these cells due to inflammation in specific areas of the brain that are known to deal with cognitive functioning and memory. Cannabinoids, or CBD, are known to target these nerve cells and act as a protector so that these cells aren't lost. CBD also acts as a natural anti-inflammatory substance to prevent mutation, as well as having antioxidant and immunosuppressive qualities. Gliosis, a term referring to the formation of scars resulting from neurological disease or injury, takes place in Alzheimer's disease, and although gliosis is a primary immune response to trauma, it is a process which permanently changes the glial cells and while doing so, impairs mental functioning. Studies have shown that CBD can reduce reactive gliosis as well as the neuroinflammatory response. These are the two most significant factors that have been linked to AD's progression. Therefore, unlike any other treatment to date, CBD is able to target the symptoms of Alzheimer's disease and possibly even stop the progression without side effects, debilitating or otherwise.

This article was posted on 2018.01.08